12:00 AM
 | 
May 20, 2013
 |  BC Week In Review  |  Financial News  |  Completed Offerings

Stemline completes follow-on

Stemline Therapeutics Inc. (NASDAQ:STML), New York, N.Y.
Business: Cancer
Date completed: 5/16/13...

Read the full 37 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >